Clinuvel Pharmaceuticals Ltd (CUVL) › Cost of RevenueClinuvel Pharmaceuticals Ltd (CUVL): Cost of RevenueAnnual figures by period end, from SEC filings.$10.98MYear ended 2026-06-30$11.51M2024-06-30: $10.74M2025-06-30: $11.51M2026-06-30: $10.98M$10.98M2024-06-30 Cost of Revenue (USD) 2026-06-30Period endedCost of RevenueChange YoYSource filing2026-06-30$10.98M-4.6%2026-10-30, From 2025-07-012025-06-30$11.51M+7.2%2026-10-30, From 2024-07-012024-06-30$10.74Mn/a2026-10-30, From 2023-07-01Other metrics: RevenueGross ProfitR&D ExpenseOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresFree Cash FlowShare RepurchasesDividends PaidShares OutstandingWeighted Average Diluted SharesEPS (Basic)